Skip to main content
Erschienen in: Herz 3/2017

05.08.2016 | Original articles

Temporal trends in transcatheter and surgical aortic valve replacement

An analysis of aortic valve replacements in Germany during 2012–2014

verfasst von: L. Gaede, W.-K. Kim, J. Blumenstein, C. Liebetrau, O. Dörr, H. Nef, C. Hamm, T. Walther, S. Achenbach, A. Elsässer, H. Möllmann

Erschienen in: Herz | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

This analysis of the data of the obligatory quality assurance programme AQUA shows the perioperative risk as well as the procedural outcome evaluated by the observed versus expected in-hospital mortality ratio (O/E ratio) of 62,872 patients undergoing isolated surgical (sAVR), transcatheter transvascular (TV-), or transapical (TA-) aortic valve replacement (TAVI) from 2012 to 2014 in Germany. The number of TAVI procedures increased from 9,352 in 2012 to 13,278 in 2014, whereas the number of sAVR remained constant (2012: 9,949; 2014: 9,953). Between 2012 and 2014, the number of TAVI implanted in patients with a logistic EuroScore I (logESI) of ≤10 % (2012: 21 %; 2014: 26 %) as well as with a logESI <20 % (2012: 57 %; 2014: 64 %) increased. In-hospital mortality in TAVI patients decreased from 5.2 % (TV: 5.0 %; TA: 7.4 %) in 2012 to 4.2 % (TV: 3.8 %; TA: 5.5 %) in 2014, whereas it was stable for sAVR patients (2012: 2.8 %; 2014: 2.6 %). The O/E ratio of TAVI patients decreased from 0.91 (TV: 0.79; TA: 1.2) to 0.73 (TV: 0.69; TA: 0.89), whereas this ratio remained constant for sAVR patients (2012: 0.92; 2014: 0.93). In summary, estimated surgical risk, in-hospital mortality, as well as the O/E ratio for patients undergoing TAVI declined constantly during the last 3 years.
Literatur
1.
Zurück zum Zitat Eggebrecht H, Mehta RH (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014 : on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11(9):1029–1033. doi:10.4244/eijy15m09_11 CrossRef Eggebrecht H, Mehta RH (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014 : on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11(9):1029–1033. doi:10.​4244/​eijy15m09_​11 CrossRef
3.
Zurück zum Zitat Smith C, Leon M, Mack M et al (2011) Transcatheter versus surgical aotic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed Smith C, Leon M, Mack M et al (2011) Transcatheter versus surgical aotic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed
4.
Zurück zum Zitat Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): In-hospital outcome. Eur Heart J 35:1588–1598CrossRefPubMed Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): In-hospital outcome. Eur Heart J 35:1588–1598CrossRefPubMed
5.
Zurück zum Zitat Kapadia SR, Leon MB, Makkar RR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2485–2491CrossRefPubMed Kapadia SR, Leon MB, Makkar RR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2485–2491CrossRefPubMed
6.
Zurück zum Zitat Mack MJ, Leon MB, Smith CR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484CrossRefPubMed Mack MJ, Leon MB, Smith CR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484CrossRefPubMed
7.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496CrossRefPubMed Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496CrossRefPubMed
8.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. doi:10.1056/NEJMoa1514616 Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. doi:10.​1056/​NEJMoa1514616
9.
Zurück zum Zitat Adams DH, Popma JJ, Reardon MJ (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371:967–968CrossRefPubMed Adams DH, Popma JJ, Reardon MJ (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371:967–968CrossRefPubMed
10.
Zurück zum Zitat Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis – complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559CrossRefPubMed Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis – complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559CrossRefPubMed
13.
Zurück zum Zitat Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793.e2CrossRefPubMed Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793.e2CrossRefPubMed
14.
Zurück zum Zitat Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977CrossRefPubMed Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977CrossRefPubMed
15.
Zurück zum Zitat Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369CrossRefPubMed Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369CrossRefPubMed
16.
Zurück zum Zitat Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operativ risk stratification models in open-heart surgery. Eur Heart J 27:867–874CrossRefPubMed Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operativ risk stratification models in open-heart surgery. Eur Heart J 27:867–874CrossRefPubMed
17.
Zurück zum Zitat Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897CrossRefPubMed Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897CrossRefPubMed
18.
Zurück zum Zitat Leon M, Smith C, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607CrossRefPubMed Leon M, Smith C, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607CrossRefPubMed
19.
Zurück zum Zitat Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76CrossRefPubMed Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76CrossRefPubMed
20.
Zurück zum Zitat Popma JJ, Adams DH, Reardon MJ et al (2014) Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63:1972–1981CrossRefPubMed Popma JJ, Adams DH, Reardon MJ et al (2014) Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63:1972–1981CrossRefPubMed
21.
Zurück zum Zitat Osswald BR, Gegouskov V, Badowski-Zyla D et al (2009) Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 30:74–80CrossRefPubMed Osswald BR, Gegouskov V, Badowski-Zyla D et al (2009) Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 30:74–80CrossRefPubMed
22.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496CrossRefPubMed Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496CrossRefPubMed
23.
Zurück zum Zitat Gaede L, Möllmann H (2015) Transcatheter aortic valve implantation (TAVI): current perspectives. Herz 54:742–751CrossRef Gaede L, Möllmann H (2015) Transcatheter aortic valve implantation (TAVI): current perspectives. Herz 54:742–751CrossRef
24.
Zurück zum Zitat Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.034 PubMed Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi:10.​1016/​j.​jacc.​2015.​03.​034 PubMed
25.
Zurück zum Zitat Adams DH, Popma JJ, Reardon MJ et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798CrossRefPubMed Adams DH, Popma JJ, Reardon MJ et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798CrossRefPubMed
26.
Zurück zum Zitat Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.014 Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi:10.​1016/​j.​jacc.​2015.​03.​014
27.
Zurück zum Zitat Rosenhek R, Iung B, Tornos P et al (2012) ESC working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822–828CrossRefPubMed Rosenhek R, Iung B, Tornos P et al (2012) ESC working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822–828CrossRefPubMed
28.
Zurück zum Zitat Sedaghat A, Sinning J‑M, Vasa-Nicotera M et al (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102:821–829CrossRefPubMed Sedaghat A, Sinning J‑M, Vasa-Nicotera M et al (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102:821–829CrossRefPubMed
Metadaten
Titel
Temporal trends in transcatheter and surgical aortic valve replacement
An analysis of aortic valve replacements in Germany during 2012–2014
verfasst von
L. Gaede
W.-K. Kim
J. Blumenstein
C. Liebetrau
O. Dörr
H. Nef
C. Hamm
T. Walther
S. Achenbach
A. Elsässer
H. Möllmann
Publikationsdatum
05.08.2016
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 3/2017
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-016-4461-1

Weitere Artikel der Ausgabe 3/2017

Herz 3/2017 Zur Ausgabe

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.